Seattle Hempfest 2015: The Slideshow

WASHINGTON:  This past weekend saw the 24th annual Seattle Hempfest in Myrtle Edwards Park along Seattle’s beautiful waterfront. Visitors came from around the country and the world to experience a treasure of the cannabis legalization movement.

While the crowds were lighter than usual due to a major rainstorm on Friday, Saturday and Sunday saw the park swell with enthusiasts, activists, and marijuana industry leaders.

The yearly ‘Protestival’ is designed to celebrate the cannabis, the cannabis community and stand as a reminder that while marijuana may be legal in Washington, there is still a long ways to go in the War On Drugs.

MJ Headline News was there to capture the crowds, the speakers, and the backstage magic. Check out the slideshow here:

USVI Senator “Positive” Nelson To Meet With Washington Marijuana Business Leaders April 14th @ Green Lion Farms

WASHINGTON: Senator Terrence “Positive” Nelson and a delegation of pro-pot politicians on a fact-finding mission from the U.S. Virgin Islands will be visiting Washington next week and meeting with Washington’s legal cannabis business community leaders, as part of the Senator’s efforts to legalize and implement a Medicinal Marijuana industry in the USVI.

While in Seattle, Senator Nelson will be the guest of honor at a “High Tea” event, presented and hosted at the SODO headquarters of Green Lion Farms, a licensed cannabis producer/processors,  and attended by leading members of Washington’s legal cannabis business community.

“The success of Washington’s Marijuana industry is very commendable and one to be imitated. Recognizing this, a delegation from the U.S. Virgin Islands will be making an exploratory trip, with the sole purpose of meeting with business owners/participants in the industry and government officials, to gather information and discuss the strategies that could assist the USVI in duplicating Washington’s success with the transition of legalizing and implementing this industry,” the Senator told MJ News Network.

The Marijuana Business Association (MJBA)  is a co-sponsor of the prestigious gathering, and MJBA CEO David Rheins has volunteered to act as emcee. High Tea takes place on Tuesday, April 14th, 3:00 PM to 6:00 PM (PDT). Tickets are $150 and available via Eventbrite.

Are There Any Marijuana Stocks To Buy In 2015?

DISTRICT OF COLUMBIA:  Perhaps nothing caught the eyes of speculative investors more than marijuana stocks in 2014, but just because marijuana stocks put up significant returns last year doesn’t mean that they can do it again in 2015. We asked our Motley Fool contributors to share their thoughts on whether there are any marijuana stocks investors might want to buy this year. Read on to learn what they think.

Todd Campbell: Most marijuana-related stocks offer more promise than they do profit, but Insys Therapeutics  (NASDAQ: INSY  )  is an exception.

Insys is developing a slate of therapies based on the marijuana cannabinoid CBD, but it’s already got a fast-growing, top-selling pain medication on the market that’s throwing off shareholder-friendly profits. That drug is Subsys, a fentanyl-based opiate that’s prescribed to treat breakthrough cancer pain. Sales of the drug jumped 105% year over year in the third quarter to $58.2 million, which led Insys to report adjusted EPS of $0.63. Thanks to Subsys, Insys is debt free, with the financial firepower necessary to advance its marijuana therapies through trials. The company expects to launch CBD trials in both Dravet Syndrome and Lennox-Gastaut Syndrome patients early this year, but it’s also been awarded orphan drug designation to study CBD in glioma, a tumor of the brain or nervous system; glioblastoma multiforme, the most common and most aggressive malignant primary brain tumor in humans; and pediatric schizophrenia. Although Insys’ research into CBD is at a very early stage, it should also soon be refiling its application for FDA approval of oral dronabinol, a new formulation of the long-standing marijuana-based chemotherapy drug Marinol. With one top seller already, another possibly coming soon, and a slate of intriguing CBD drugs in its pipeline, Insys is a stock investors may want to own.